Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature

References

• American Psychiatric Association. 2010. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Washington (DC): APA.
   Google Scholar
• Andrews G. 2001. Should depression be managed as a chronic disease? BMJ. 322(7283):419–421. doi:10.1136/bmj.322.7283.419
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L. 2019. Effects of treatment discontinuation in clinical psychopharmacology. Psychother Psychosom. 88(2):65–70. doi:10.1159/000497334
   PubMed Web of Science ®Google Scholar
• Bayes AJ, Parker GB. 2018. Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation. Acta Psychiatr Scand. 137(6):459–471. doi:10.1111/acps.12878
   PubMed Web of Science ®Google Scholar
• Berwian IM, Walter H, Seifritz E, Huys QJ. 2017. Predicting relapse after antidepressant withdrawal - a systematic review . Psychol Med. 47(3):426–437. doi:10.1017/S0033291716002580
   PubMed Web of Science ®Google Scholar
• Bockting CL, Mascha C, Spijker J, Spinhoven P, Koeter MW, Schene AH, DELTA study group 2008. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom. 77(1):17–26. doi:10.1159/000110056
   PubMed Web of Science ®Google Scholar
• Borges S, Chen YF, Laughren TP, Temple R, Patel HD, David PA, Mathis M, Unger E, Yang P, Khin NA, et al. 2014. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry. 75(03):205–214. doi:10.4088/JCP.13r08722
   PubMed Web of Science ®Google Scholar
• Bosman RC, Waumans RC, Jacobs GE, Voshaar RCO, Muntingh AD, Batelaan NM, van Balkom AJ. 2018. Failure to respond after reinstatement of antidepressant medication: a systematic review. Psychother Psychosom. 87(5):268–275. doi:10.1159/000491550
   PubMed Web of Science ®Google Scholar
• Bschor T, Kern H, Henssler J, Baethge C. 2018. Switching the antidepressant after nonresponse in adults with major depression: a systematic literature search and meta-analysis. J Clin Psychiatry. 79(1):16r10749. doi:10.4088/JCP.16r10749
   PubMed Web of Science ®Google Scholar
• Buckman JEJ, Underwood A, Clarke K, Saunders R, Hollon SD, Fearon P, Pilling S. 2018. Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and meta-synthesis. Clin Psychol Rev. 64:13–38. doi:10.1016/j.cpr.2018.07.005
   PubMed Web of Science ®Google Scholar
• Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B. 2002. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 288(11):1403–1409. doi:10.1001/jama.288.11.1403
   PubMed Web of Science ®Google Scholar
• Byrne SE, Rothschild AJ. 1998. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 59(6):279–288. doi:10.4088/jcp.v59n0602
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. 2016. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 85(5):270–288. doi:10.1159/000447034
   PubMed Web of Science ®Google Scholar
• Chouinard G, Chouinard VA. 2015. New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom. 84(2):63–71. doi:10.1159/000371865
   PubMed Web of Science ®Google Scholar
• Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Members of the Consensus Meeting, et al. 2015. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol (Oxford). 29(5):459–525. doi:10.1177/0269881115581093
   PubMed Web of Science ®Google Scholar
• Cohen D, Récalt A. 2019. Discontinuing psychotropic drugs from participants in randomized controlled trials: a systematic review. Psychother Psychosom. 88(2):96–104. doi:10.1159/000496733
   PubMed Web of Science ®Google Scholar
• Concato J, Horwitz RI. 2019. Limited usefulness of meta-analysis for informing patient care. Psychother Psychosom. 88(5):257–262. doi:10.1159/000502530
   PubMed Web of Science ®Google Scholar
• Cosci F, Chouinard G. 2020. Withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 1–24. doi:10.1159/000506868.
   Web of Science ®Google Scholar
• Cosci F, Fava GA. 2013. Staging of mental disorders: systematic review. Psychother Psychosom. 82(1):20–34. doi:10.1159/000342243
   PubMed Web of Science ®Google Scholar
• Cuffel BJ, Azocar F, Tomlin M, Greenfield SF, Busch AB, Croghan TW. 2003. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry. 64(4):397–402. doi:10.4088/jcp.v64n0406
   PubMed Web of Science ®Google Scholar
• Davies J, Read J. 2019. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav. 97:111–121. doi:10.1016/j.addbeh.2018.08.027
   PubMed Web of Science ®Google Scholar
• Dold M, Bartova L, Rupprecht R, Kasper S. 2017. Dose escalation of antidepressants in unipolar depression: a meta-analysis of double-blind, randomized controlled trials. Psychother Psychosom. 86(5):283–291. doi:10.1159/000477770
   PubMed Web of Science ®Google Scholar
• Dunlop BW, LoParo D, Kinkead B, Mletzko-Crowe T, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE. 2019. Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. Am J Psychiatry. 176(4):275–286. doi:10.1176/appi.ajp.2018.18091075
   PubMed Web of Science ®Google Scholar
• Eveleigh R, Speckens A, van Weel C, Oude Voshaar R, Lucassen P. 2019. Patients’ attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators. Ther Adv Psychopharmacol. 9:2045125319872344. doi:10.1177/2045125319872344
   Web of Science ®Google Scholar
• Faravelli C, Cosci F, Ciampelli M, Scarpato MA, Spiti R, Ricca V. 2003. A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants. Psychother Psychosom. 72(2):95–101. doi:10.1159/000068689
   PubMed Web of Science ®Google Scholar
• Fava GA. 1999a. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med. 29(1):47–61. doi:10.1017/s0033291798007429
   PubMed Web of Science ®Google Scholar
• Fava GA. 1999b. Conceptual obstacles to research progress in affective disorders. Psychother Psychosom. 66(6):283–285. doi:10.1159/000289149
   Web of Science ®Google Scholar
• Fava GA. 2003. Can long-term treatment with antidepressant drugs worsen the course of depression?. J Clin Psychiatry. 64(2):123–133. doi:10.4088/jcp.v64n0204
   PubMed Web of Science ®Google Scholar
• Fava GA. 2014. Rational use of antidepressant drugs. Psychother Psychosom. 83(4):197–204. doi:10.1159/000362803
   PubMed Web of Science ®Google Scholar
• Fava GA. 2016. Well-being therapy: treatment manual and clinical applications. Basel: Karger Medical and Scientific Publishers.
   Google Scholar
• Fava GA, Belaise C. 2018. Discontinuing antidepressant drugs: lesson from a failed trial and extensive clinical experience. Psychother Psychosom. 87(5):257–267. doi:10.1159/000492693
   PubMed Web of Science ®Google Scholar
• Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. 2018. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom. 87(4):195–203. doi:10.1159/000491524
   PubMed Web of Science ®Google Scholar
• Fava GA, Cosci F. 2019. Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs. J Clin Psychiatry. 80(6):19com12794. doi:10.4088/JCP.19com12794
   PubMed Web of Science ®Google Scholar
• Fava GA, Cosci F, Guidi J, Tomba E. 2017. Well-being therapy in depression: new insights into the role of psychological well-being in the clinical process . Depress Anxiety. 34(9):801–808. doi:10.1002/da.22629
   PubMed Web of Science ®Google Scholar
• Fava GA, Cosci F, Offidani E, Guidi J. 2016. Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment. J Clin Psychopharmacol. 36(6):550–553. doi:10.1097/JCP.0000000000000570
   PubMed Web of Science ®Google Scholar
• Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. 2015. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom. 84(2):72–81. doi: 10.1159/000491524 doi:10.1159/000370338
   PubMed Web of Science ®Google Scholar
• Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA. 1994. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry. 151(9):1295–1299. doi:10.1176/ajp.151.9.1295
   PubMed Web of Science ®Google Scholar
• Fava GA, Guidi J. 2020. The pursuit of euthymia. World Psychiatry. 19(1):40–50. doi:10.1002/wps.20698
   PubMed Web of Science ®Google Scholar
• Fava M, Kendler KS. 2000. Major depressive disorder. Neuron. 28(2):335–341. doi:10.1016/s0896-6273(00)00112-4
   PubMed Web of Science ®Google Scholar
• Fava GA, Molnar G, Grandi S, Sonino N. 1991. Prodromal symptoms and intermittent drug medication in mood disorders. Pharmacopsychiatry. 24(1):28–30. doi:10.1055/s-2007-1014429
   PubMed Web of Science ®Google Scholar
• Fava GA, Offidani E. 2011. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 35(7):1593–1602. doi:10.1016/j.pnpbp.2010.07.026
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Belaise C. 2007. The concept of recovery in major depression. Psychol Med. 37(3):307–317. doi:10.1017/S0033291706008981
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. 2004. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 161(10):1872–1876. doi:10.1176/ajp.161.10.1872
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Sonino N. 2003. Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs. 17(15):1109–1117. doi:10.2165/00023210-200317150-00005
   PubMed Web of Science ®Google Scholar
• Fava GA, Tomba E. 2010. New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs. 24(6):453–465. doi:10.2165/11531580-000000000-00000
   PubMed Web of Science ®Google Scholar
• Fava GA, Rafanelli C. 2019. Iatrogenic factors in psychopathology. Psychother Psychosom. 88(3):129–140. doi:10.1159/000500151
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, et al. 2003. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 361(9358):653–661. doi:10.1016/S0140-6736(03)12599-8
   PubMed Web of Science ®Google Scholar
• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. 2017. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2
   PubMed Web of Science ®Google Scholar
• Glue P, Donovan MR, Kolluri S, Emir B. 2010. Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Aust N Z J Psychiatry. 44(8):697–705. doi:10.3109/00048671003705441
   PubMed Web of Science ®Google Scholar
• Gopinath S, Katon WJ, Russo JE, Ludman EJ. 2007. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. J Affect Disord. 101(1–3):57–63. doi:10.1016/j.jad.2006.10.023
   PubMed Web of Science ®Google Scholar
• Guidi J, Tomba E, Cosci F, Park SK, Fava GA. 2017. The role of staging in planning psychotherapeutic interventions in depression. J Clin Psychiatry. 78(4):456–463. doi:10.4088/JCP.16r10736
   PubMed Web of Science ®Google Scholar
• Guidi J, Tomba E, Fava GA. 2016. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 173(2):128–137. doi:10.1176/appi.ajp.2015.15040476
   PubMed Web of Science ®Google Scholar
• Hengartner MP, Angst J, Rössler W. 2018. Antidepressant use prospectively relates to a poorer long-term outcome of depression: results from a prospective community cohort study over 30 years. Psychother Psychosom. 87(3):181–183. doi:10.1159/000488802
   PubMed Web of Science ®Google Scholar
• Hung CI. 2014. Factors predicting adherence to antidepressant treatment. Curr Opin Psychiatry. 27(5):344–349. doi:10.1097/YCO.0000000000000086
   PubMed Web of Science ®Google Scholar
• Judd LL. 1997. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry. 54(11):989–991. doi:10.1001/archpsyc.1997.01830230015002
   PubMed Web of Science ®Google Scholar
• Kaymaz N, van Os J, Loonen AJM, Nolen WA. 2008. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 69(9):1423–1436. doi:10.4088/JCP.v69n0910
   PubMed Web of Science ®Google Scholar
• Kendler KS, Thornton LM, Gardner CO. 2000. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 157(8):1243–1251. doi:10.1176/appi.ajp.157.8.1243
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, CANMAT Depression Work Group, et al. 2016. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 61(9):540–560. doi:10.1177/0706743716659417
   PubMed Web of Science ®Google Scholar
• Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Jr, Kasper S. 2019. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 9(1):127. doi:10.1038/s41398-019-0460-3
   PubMed Web of Science ®Google Scholar
• Kupfer DJ. 1992. Maintenance treatment in recurrent depression: current and future directions. The first William Sargant Lecture. Br J Psychiatry. 161:309–316. doi:10.1192/bjp.161.3.309
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Frank E, Perel JM. 1989. The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry. 46(9):771–775. doi:10.1001/archpsyc.1989.01810090013002
   PubMed Web of Science ®Google Scholar
• Linden M. 2013. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother. 20(4):286–296. doi:10.1002/cpp.1765
   PubMed Web of Science ®Google Scholar
• Medina JC, Schmelefske E, Hébert C, Drapeau M. 2020. European clinical practice guidelines for depression in adults: are they good enough? J Affect Disord. 263:382–385. doi:10.1016/j.jad.2019.12.005
   PubMed Web of Science ®Google Scholar
• Mergl R, Henkel V, Allgaier AK, Kramer D, Hautzinger M, Kohnen R, Coyne J, Hegerl U. 2011. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients’ choice arm. Psychother Psychosom. 80(1):39–47. doi:10.1159/000318772
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. 2018. Depression in adults: treatment and management. Full guideline. Consultation draft. [accessed May 2018]. www.nice.org.uk/guidance/gid-cgwave0725/documents/full-guideline-updated
   Google Scholar
• Olfson M, Marcus SC, Tedeschi M, Wan GJ. 2006. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 163(1):101–108. doi:10.1176/appi.ajp.163.1.101
   PubMed Web of Science ®Google Scholar
• Parry GD, Crawford MJ, Duggan C. 2016. Iatrogenic harm from psychological therapies-time to move on. Br J Psychiatry. 208(3):210–212. Mardoi:10.1192/bjp.bp.115.163618
   PubMed Web of Science ®Google Scholar
• Paykel ES. 2008. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 10(4):431–437.
   PubMedGoogle Scholar
• Piet J, Hougaard E. 2011. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev. 31(6):1032–1040. doi:10.1016/j.cpr.2011.05.002
   PubMed Web of Science ®Google Scholar
• Raue PJ, Schulberg HC, Heo M, Klimstra S, Bruce ML. 2009. Patients’ depression treatment preferences and initiation, adherence, and outcome: a randomized primary care study. Psychiatr Serv. 60(3):337–343. doi:10.1176/appi.ps.60.3.337
   PubMed Web of Science ®Google Scholar
• Récalt AM, Cohen D. 2019. Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000–2017. Psychother Psychosom. 88(2):105–113. doi:10.1159/000496734
   PubMed Web of Science ®Google Scholar
• Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M. 2014. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Compr Psychiatry. 55(1):1–10. doi:10.1016/j.comppsych.2013.08.008
   PubMed Web of Science ®Google Scholar
• Sansone RA, Sansone LA. 2012. Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci. 9(5–6):41–46.
   PubMedGoogle Scholar
• Savard M. 2004. Bridging the communication gap between physicians and their patients with physical symptoms of depression. Prim Care Companion J Clin Psychiatry. 6(Suppl 1):17–24.
   PubMedGoogle Scholar
• Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. 2016. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. IJNPPY. 19(2):pyv076. doi:10.1093/ijnp/pyv076
   Google Scholar
• Simon GE, VonKorff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH. 1996. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA. 275(24):1897–1902. doi:10.1001/jama.1996.03530480039038
   PubMed Web of Science ®Google Scholar
• Taylor DJ, Walters HM, Vittengl JR, Krebaum S, Jarrett RB. 2010. Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence? J Affect Dis. 123(1–3):181–187. doi:10.1016/j.jad.2009.08.007
   PubMed Web of Science ®Google Scholar
• Tomba E, Fava GA. 2012. Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am. 35(1):87–98. doi:10.1016/j.psc.2011.11.003
   PubMed Web of Science ®Google Scholar
• van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P. 2010. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res. 69(1):23–32. doi:10.1016/j.jpsychores.2010.01.019
   PubMed Web of Science ®Google Scholar
• Viguera AC, Baldessarini RJ, Friedberg J. 1998. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry. 5(6):293–306. doi:10.3109/10673229809003578
   PubMed Web of Science ®Google Scholar
• World Health Organization 2012. Duration of antidepressant treatment. Geneva: WHO.
   Google Scholar
• Zafra-Tanaka JH, Goicochea-Lugo S, Villarreal-Zegarra D, Taype-Rondan A. 2019. Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review. BMC Psychiatry. 19(1):76. doi:10.1186/s12888-019-2057-z
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang L, Zhang G, Jin J, Zheng Z. 2018. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis. BMC Psychiatry. 18(1):50. doi:10.1186/s12888-018-1610-5
   PubMedGoogle Scholar
• Zimmerman M, Balling C, Chelminski I, Dalrymple K. 2019. Have treatment studies of depression become even less generalizable? Applying the inclusion and exclusion criteria in placebo-controlled antidepressant efficacy trials published over 20 years to a clinical sample. Psychother Psychosom. 88(3):165–170. doi:10.1159/000499917
   PubMed Web of Science ®Google Scholar